Drug resistance in renal tumors of childhood

Current Pharmaceutical Biotechnology

Volumn 8, Issue 2, 2007, Pages 99-104

  Ramachandran, Cheppail ^a  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

Chemotherapy; Childhood renal tumor; Functional assay; Molecular diagnosis; Multidrug resistance; Resistance modifiers

Indexed keywords

ABC TRANSPORTER; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; AZIDOPINE; BIRICODAR; BREAST CANCER RESISTANCE PROTEIN; CHLORPROMAZINE; CYCLOSPORIN A; CYTOTOXIC AGENT; DEXNIGULDIPINE; DEXVERAPAMIL; DILTIAZEM; DOCETAXEL; DOXORUBICIN; FUMITREMORGIN C; GENISTEIN; GLYCOPROTEIN P; LANIQUIDAR; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; NAVELBINE; NICARDIPINE; QUININE DERIVATIVE; QUINOLINE; TARIQUIDAR; TRIFLUOPERAZINE; UNINDEXED DRUG; VALSPODAR; VERAPAMIL; ZOSUQUIDAR;

BONE MARROW TOXICITY; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONSENSUS; DNA MICROARRAY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EXCRETION; DRUG SYNTHESIS; DRUG TREATMENT FAILURE; GENE AMPLIFICATION; GENETIC CODE; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY CELL; KIDNEY TUMOR; MOLECULAR PROBE; MULTIDRUG RESISTANCE; NEUTROPENIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MICROARRAY; QUANTITATIVE ANALYSIS; REVIEW; TUMOR CELL; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, NEOPLASM; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34248178315     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920107780487447     Document Type: Review

References (82)

1. Charles, A.K.; Vujanic, G.M. and Berry, P.J. (1998) Histopathology, 32, 293-303.
2. Geller, E.; Smergel, E.M. and Lowry PA. (1997) Radiol. Clin. North Am., 35, 1391-1413.
3. Farber, S.; Diamond, L.K.; Mercer, R.D.; Sylvester, R.F. and Wolff, V.A. (1948) N. Engl. J. Med., 238, 787-793.
4. Biedler, J.L. and Riehm, H. (1970) Cancer Res., 30, 1174-1184.
5. Juliano, R.L. and Ling V. (1976) Biochim. Biophys. Acta, 455, 152-162.
6. Kartner, N.; Riordan, J.R. and Ling V. (1983) Science, 221, 1285-1288.
7. Gottesman, M.M. and Pastan, I. (1993) Annu. Rev. Biochem., 62, 385-427.
8. Moscow, J.A. and Cowan, K.H. (1988) J. Natl. Cancer Inst., 80, 14-20.
9. Biedler, J.L. (1992) Cancer (Supplement), 70, 1799-1809.
10. Endicott, J.A. and Ling, V. (1989) Annu. Rev. Biochem., 58, 137-171.
11. Gros, P.; Ben Neriah, Y.B.; Croop, J.M. and Housman, D.E. (1986) Nature, 323, 728-731.
12. Ueda, K.; Carderelli, C.; Gottesman, M.M. and Pastan, I. (1987) Proc. Natl. Acad. Sci. USA, 84, 3004-3008.
13. Guild, B.; Mulligan, R.; Gros, P. and Houseman, D. (1988) Proc. Natl. Acad. Sci. USA, 85, 1595-1599.
14. Pastan, I.; Gottesman, M.M.; Ueda, K.; Lovelace, E.; Rutherford, A.V. and Willingham, M.C. (1988) Proc. Natl. Acad. Sci. USA, 85, 4486-4490.
15. Stein, W.D.; Cardarelli, C.O.; Pastan, I. and Gottesman, M.M. (1994) Mol. Pharmacol., 45, 763-772.
16. Cole, S.P.C.; Bhardwaj, G.; Gerlach, J.H.; Mackie, J.E.; Grant, C.E.; Almquist, K.C.; Stewart, A.J.; Kurz, E.U.; Duncan, A.M. and Deeley, R.G. (1992) Science 258, 1650-1654.
17. Marquardt, D.; McCrone, S. and Center, M.S. (1990) Cancer Res., 50, 1426-1430.
18. Grant, C.E.; Valdimarsson, G.; Hipfner, D.R.; Almquist, K.C.; Cole, S.P. and Deeley, R,G. (1994) Cancer Res., 54, 357-361.
19. Cole, S.P.C.; Sparks, K.E.; Fraser, K.; Loe, D.W.; Grant, C.E.; Wilson, G.M. and Deeley, R. (1994) Cancer Res., 54, 5902-5910.
20. Muller, M.; Meijer, C.; Zaman, G.J.R.; Borst, P.; Scheper, R.J.; Mulder, N.H.; de Vries, E.G. and Jansen, P.L. (1994) Proc. Natl. Acad Sci. USA, 91, 13033-13037.
21. Brock, I.; Hipfner, D.R.; Nielsen, B.S.; Jensen, P.B.; Deeley, R.G.; Cole, S.P.; Sehested, M. (1995) Cancer Res., 55, 459-462.
22. Slapak, C.A.; Mizunuma, N. and Kufe, D.W. (1994) Blood, 84, 3113-3121.
23. Hasegawa, S.; Abe, T.; Naito, S.; Kotoh, S.; Kumazawa, J.; Hipfner, D.R.; Deeley, R.G.; Cole, S.P. and Kuwano, M. (1995) Br. J. Cancer, 71, 907-913.
24. McGrath, T. and Center, M.S. (1988) Cancer Res., 48, 3959-3963.
25. Schuurhuis, G.J.; van Heijningen, T.H.M.; Cervantes, A.; Pinedo, H.M.; de Lange, J.H.; Keizer, H.G.; Broxterman, H.J.; Baak, J.P. and Lankelma, J. (1993) Br. J. Cancer, 68, 898-908.
26. Schuurhuis, G.J.; Broxterman, H.J.; De Lange, J.H.; Pinedo, H.M.; van Heijningen, T.H.; Kuiper, C.M.; Scheffer, G.L.; Scheper, R.J.; van Kalken, C.K. and Baak, J.P. (1991) Br. J. Cancer, 64, 857-861.
27. Cole, S.P.; Pinkoski, M.J.; Bhardwaj, G. and Deeley, R.G. (1992) Br. J. Cancer, 65, 498-502.
28. Harder, T. and Gerke,V. (1993) J. Cell Biol., 123, 1119-1132.
29. Burgoyne, R.D. and Clague, M. (1994) Trend Biochem. Sci., 19, 231-232.
30. Marquardt, D. and Center M.S. (1992) Cancer Res. 52, 3157-3163.
31. Versanvoort, C.H.M.; Broxterman, H.J.; Bagrij, T.; Scheper, R.J. and Twentyman, P.R. (1995) Br. J. Cancer, 72, 82-89.
32. Zaman, G.J.R.; Lankelma, J.; Van Tellingen, O.; Beijnen, J.; Dekker, H.; Paulusma, C.; Oude Elferink, R.P.; Baas, F. and Borst, P. (1995) Proc. Natl. Acad. Sci. USA, 92, 7690-7694.
33. Scheper, R.J.; Broxterman, H.J.; Scheffer, G.L.; Kaaijk, P.; Dalton, W.S.; van Heijningen, T.H.; van Kalken, C.K.; Slovak, M.L.; de Vries, E.G. and van der Valk, P. (1993) Cancer Res., 53, 1475-1479.
34. Scheffer, G.L.; Wijngaard, P.L.; Flens, M.J.; Izquierdo, M.A.; Slovak, M.L.; Pinedo, H.M.; Meijer, C.J.; Clevers, H.C. and Scheper, R.J. (1995) Nat Med., 1, 578-582.
35. Futscher, B.W.; Abbaszadegan, M.R.; Domann, F. and Dalton, W.S. (1994) Biochem. Pharmacol., 47, 1601-1606.
36. Versantvoort, C.H.M.; Withoff, S.; Broxterman, H.J.; Kuiper, C.M.; Scheper, R.J.; Mulder, N.H. and de Vries, E.G. (1995) Int. J. Cancer, 61, 375-380.
37. Flens, M.J.; Izquierdo, M.A.; Scheffer, G.L.; Fritz, J.M.; Meijer, C.J.; Scheper, R.J. and Zaman, G.J. (1994) Cancer Res., 54, 4557-4563.
38. Slovak, M.L.; Ho, J.P.; Bhardwaj, G.; Kurz, E.U.; Deeley, R.G. and Cole, S.P. (1993) Cancer Res., 53, 3221-3225.
39. Rome, L.H.; Kedersha, N.L. and Chugani, D.C. (1991) Trends Cell Biol., 1, 47-50.
40. Kedersha, N.L. and Rome, L.H. (1986) J. Cell Biol., 103, 699-709.
41. Izquierdo, M.A.; Shoemaker, R.H.; Flens, M.J.; Scheffer, G.L.; Wu, L.; Prather, T.R. and Scheper, R.J. (1996) Int. J. Cancer, 65, 230-237.
42. Izquierdo, M.A.; Scheffer, G.L.; Flens, M.J.; Giaccone, G.; Broxterman, H.J.; Meijer, C.J.; van der Valk, P. and Scheper, R.J. (1996) Am. J. Pathol., 148, 877-887.
43. Izquierdo, M.A.; Scheffer, G.L.; Flens, M.J.; Schroeijers, A.B.; van der Valk, P. and Scheper, R.J. (1996) Eur. J. Cancer, 32A, 979-984.
44. Doyle, L.A.; Yang, W.; Abruzzo, L.V.; Krogmann, T.; Gao, Y.; Rishi, A.K. and Ross, D.D. (1998) Proc. Natl. Acad. Sci. USA, 95, 15665-15670.
45. Ejendal, K.R. and Hrycyna, C.A. (2002) Curr. Protein Pept. Sci., 3, 503-511.
46. Ramachandran, C.; You, W. and Krishan, A. (1997) Proc. Am. Assoc. Cancer Res., 38, 389.
47. Ramachandran, C.; You, W. and Krishan, A. (1998) Proc. Am. Assoc. Cancer Res., 39, 557.
48. Allikmets, R.; Schriml, L.M.; Hutchinson, A.; Romano-Spica, V. and Dean, M. (1998) Cancer Res. 58, 5337-5339.
49. Krishna, R. and Mayer, L.D. (2000) Eur. J. Pharm. Sci., 11, 265-283.
50. Ferry, D.R.; Traunecker, H. and Kerr, D.J. (1996) Eur. J. Cancer, 32A, 1070-1081.
51. Ambudkar, S.V.; Dey, S.; Hrycyna, C.A.; Ramachandra, M.; Pastan, I. and Gottesman, M.M. (1999) Annu. Rev. Pharmacol. Toxicol., 39, 361-398.
52. te Boekhorst, P.A.; van Kapel, J.; Shoester, M. and Sonneveld, P. (1992) Cancer Chemother. Pharmacol., 30, 238-242.
53. Twentyman, P.R. and Bleehen, N.M. (1991) Eur. J. Cancer, 27, 1639-1642.
54. Thomas, H. and Coley, H.M. (2003) Cancer Control, 10, 159-165.
55. Wandel, C.; Kim, R.B.; Kajiji, S.; Guengerich, P.; Wilkinson, G.R. and Wood, A.J. (1999) Cancer Res., 59, 3944-3948.
56. Dantzig, A.H.; Shepard, R.L.; Law, K.L.; Tabas, L.; Pratt, S.; Gillespie, J.S.; Binkley, S.N.; Kuhfeld, M.T.; Starling, J.J.; Wrighton, S.A. (1999) J. Pharmacol. Exp. Ther., 290, 854-862.
57. Mistry, P.; Stewart, A.J.; Dangerfield, W.; Okiji, S.; Liddle, C.; Bootle, D.; Plumb, J.A.; Templeton, D. and Charlton, P. (2001) Cancer Res., 61, 749-758.
58. Roe, M.; Folkes, A.; Ashworth, P.; Brumwell, J.; Chima, L.; Hunjan, S.; Pretswell, I.; Dangerfield, W.; Ryder, H. and Charlton, P. (1999) Bioorg. Med. Chem. Lett., 9, 595-600.
59. Starling, J.J.; Shepard, R.L.; Cao, J.; Law, K.L.; Norman, B.H.; Kroin, J.S.; Ehlhardt, W.J.; Baughman, T.M.; Winter, M.A.; Bell, M.G.; Shih, C.; Gruber, J.; Elmquist, W.F. and Dantzig, A.H. (1997) Adv. Enzyme Regul., 37, 335-347.
60. Dantzig, A.H.; Shepard, R.L.; Cao, J.; Law, K.L.; Ehlhardt, W.J.; Baughman, T.M.; Bumol, T.F. and Starling, J.J. (2001) Cancer Res., 61, 749-758.
61. van Zuylen, L.; Nooter, K.; Sparreboom, A. and Verweij, J. (2000) Invest. New Drugs, 18, 205-220.
62. Newman, M.J.; Rodarte, J.C.; Benbatoul, K.D.; Romano, S.J.; Zhang, C.; Krane, S.; Moran, E.J.; Uyeda, R.T.; Dixon, R.; Guns, E.S. and Mayer, L.D. (2000) Cancer Res., 60, 2964-2972.
63. Maliepaard, M.; van Gastelen, M.A.; Tohgo, A.; Hausheer, FH.; van Waardenburg, R.C.; de Jong, L.A.; Pluim, D.; Beijnen, J.H. and Schellens, J.H. (2001) Clin. Cancer Res., 7, 935-941.
64. Fojo, A.T.; Ueda, K.; Slamon, D.J.; Poplack, D.G.; Gottesman, M.M. and Pastan, I. (1987) Proc. Natl. Acad. Sci. USA, 84, 265-269.
65. Kakehi, Y.; Kanamru, H.; Yoshida, O.; Ohkubo, H.; Nakanishi, S.; Gottesman, M.M. and Pastan, I. (1988) J. Urol., 139, 862-865.
66. Goldstein, L.J.; Galski, H.; Fojo, A.; Willingham, M.; Lai, S.L.; Gazdar, A.; Pirker, R.; Green, A.; Crist, W. and Brodeur, G.M. (1989) J. Natl. Cancer Inst., 81, 116-124.
67. Kanamaru, H.; Kakehi, Y.; Yoshida, O.; Nakanishi, S.; Pastan, I. and Gottesman, M.M. (1989) J. Natl. Cancer Inst., 81, 844-849.
68. Mickisch, G.H.; Bier, H.; Bergler, W.; Tschada, R. and Aiken, P. (1990) Urol. Int., 45, 170-176.
69. Volm, M.; Mattern, J.; Stammler, G.; Royer-Pokora, B.; Schneider, S.; Wetrich, A. and Ludwig, R. (1995) Int. J. Cancer, 63, 193-197.
70. Reinecke, P.; Schmitz, M.; Schneider, E.M.; Gabbert, H.E. and Gerharz, C-D. (2000) Cancer Invest., 18, 614-625.
71. Mickisch, G.H.; Merlino, G.T.; Aiken, P.M.; Gottesman, M.M. and Pastan, I. (1991) J. Urol., 146, 447-453.
72. Mickisch, G.H.; Kossig, J.; Tschada, R.K.; Keilhauer, G.; Schlick, E. and Aiken, P.M. (1991) Urol. Int., 47, 118-125.
73. Kawamoto, S.; Deguchi, T.; Shinichi, N.; Yamada, S.; Okano, M. and Kawada, Y. (1996) Jpn. J. Cancer Res., 87, 475-479.
74. Ramp, U.; Dejosez, M.; Mahotka, C.; Czarnotta, B.; Kalinski, T.; Wenzel, M.; Lorenz, I.; Muller, M.; Krammer, P.; Gabbert, H.E. and Gerharz, C.D. (2000) Br. J. Cancer, 82, 1851-1859.
75. Yu, D-S.; Sun, G-H.; Ma, C-P.; Chang, S-Y. (1999) Urology, 54, 377-381.
76. Scheltema, J.M.W.; Romijn, J.C.; van Steenbrugge, G.J.; Schroeder, F.H. and Mickisch, G.H. (1990) Anticancer Res., 21, 3161-3166.
77. Gamelin, E.; Mertins, S.D.; Regis, J.T.; Mickley, L.; Abati, A.; Worrell, R.A.; Linehan, W.M. and Bates, S.E. (1999) J. Urol., 162, 217-224.
78. Ramachandran, C.; Melnick, S.J.; Escalon, E.; Jhabvala, P.; Khatib, Z.; Alamo, A. and Smith, S. (2000) Anticancer Res., 20, 3759-3766.
79. Beck, W.T.; Grogan, T.M.; Willman, C.L.; Cordon-Cardo, C.; Parham, D.M.; Kuttesch, J.F.; Andreeff, M.; Bates, S.E.; Berard, C.W.; Boyett, J.M.; Brophy, N.A.; Broxterman, H.J.; Chan, H.S.; Dalton, W.S.; Dietel, M.; Fojo, A.T.; Gascoyne, R.D.; Head, D.; Houghton, P.J.; Srivastava, D.K.; Lehnert, M.; Leith, C.P.; Paietta, E.; Pavelic, Z.P. and Weinstein, R. (1996) Cancer Res., 56, 3010-3020.
80. Marie, J-P.; Legrand, O.; Perrot, JY.; Chevillar, S.; Huet, S. and Robert, J. (1997) Semin. Hematol., 34 (Suppl. 5), 63-71.
81. Dietel, M. (1993) Cancer Res., 53, 2683-2688.
82. Lehnert, M. (1996) Eur. J. Cancer, 32A, 912-930.